| Date |
Research Question / Title |
Unique ID |
Research Team |
|
March 11, 2022
|
Do motivational interviewing (MI) techniques effectively address vaccine hesitancy?
|
EOC220301 ESR
|
EOC
|
|
December 26, 2021
|
How effective are COVID-19 vaccines? [Evergreen]
|
INF031801v019 RR
|
Infectious Disease
|
|
January 14, 2022
|
How effective are COVID-19 vaccines? [Evergreen]
|
INF031801v020 ESR
|
Infectious Disease
|
|
December 15, 2020
|
How is COVID-19 transmitted from person-to-person and what is the most common source of transmission?
|
INF121501-01 ESR
|
Infectious Disease
|
|
December 17, 2020
|
How is COVID-19 transmitted from person-to-person and what is the most common source of transmission?
|
INF121501 RR
|
Infectious Disease
|
|
May 2022
|
Motivational Interviewing for Vaccine Hesitancy - Situation, Background, Assessment, Recommendation (SBAR)
|
EOC220301 SBAR
|
EOC
|
|
March 11, 2022
|
What are long COVID's demands on the healthcare system, and its
severity of the illness?
|
EPM210602v2 ESR
|
Epidemiology & Modelling
|
|
June 3, 2022
|
What are long COVID's demands on the healthcare system, and its
severity of the illness?
|
EPM210602v003 ESR
|
Epidemiology & Modelling
|
|
June 20, 2022
|
What are long COVID's demands on the healthcare system, and its
severity of the illness?
|
EPM210602v002 RR
|
Epidemiology & Modelling
|
|
March 11, 2021
|
What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)?
|
EOC031001-01 ESR
|
EOC
|
|
March 18, 2021
|
What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)?
|
EOC031001 RR
|
EOC
|
|
June 1, 2021
|
What are the ethical/legal aspects of vaccine requirements?
|
EOC210503 ESR
|
EOC
|
|
June 21, 2021
|
What are the ethical/legal aspects of vaccine requirements?
|
EOC210503 RR
|
EOC
|
|
April 1, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 ESR
|
EOC
|
|
April 21, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 RR
|
EOC
|
|
March 4, 2021
|
What are the vaccination strategies for vulnerable populations?
|
PH030401-01 ESR
|
Public Health
|
|
March 12, 2021
|
What are the vaccination strategies for vulnerable populations?
|
PH030401 RR
|
Public Health
|
|
September 17, 2020
|
What evidence is there to support medical exemptions for mask wearing?
|
EOC091101 RR
|
EOC
|
|
23-Apr-2020
|
What frequency of repeat population screening will be required?
|
LAB042202-01 ESR
|
Laboratory
|
|
April 25, 2020
|
What frequency of repeat population screening will be required?
|
LAB042202 RR
|
Laboratory
|
